These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 11220414)

  • 1. Vancomycin-resistant enterococci.
    McGeer AJ; Low DE
    Semin Respir Infect; 2000 Dec; 15(4):314-26. PubMed ID: 11220414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units.
    Fridkin SK; Edwards JR; Courval JM; Hill H; Tenover FC; Lawton R; Gaynes RP; McGowan JE;
    Ann Intern Med; 2001 Aug; 135(3):175-83. PubMed ID: 11487484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vancomycin resistant Enterococci (VRE)].
    Lesens O
    Nephrol Ther; 2009 Jun; 5 Suppl 4():S261-4. PubMed ID: 19596346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC).
    MMWR Recomm Rep; 1995 Sep; 44(RR-12):1-13. PubMed ID: 7565541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study to determine whether cover gowns in addition to gloves decrease nosocomial transmission of vancomycin-resistant enterococci in an intensive care unit.
    Srinivasan A; Song X; Ross T; Merz W; Brower R; Perl TM
    Infect Control Hosp Epidemiol; 2002 Aug; 23(8):424-8. PubMed ID: 12186206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit.
    Slaughter S; Hayden MK; Nathan C; Hu TC; Rice T; Van Voorhis J; Matushek M; Franklin C; Weinstein RA
    Ann Intern Med; 1996 Sep; 125(6):448-56. PubMed ID: 8779456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany - 10 years of surveillance.
    Remschmidt C; Schröder C; Behnke M; Gastmeier P; Geffers C; Kramer TS
    Antimicrob Resist Infect Control; 2018; 7():54. PubMed ID: 29760912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment options for vancomycin-resistant enterococcal infections.
    Linden PK
    Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin resistant enterococci healthcare associated infections.
    Orsi GB; Ciorba V
    Ann Ig; 2013; 25(6):485-92. PubMed ID: 24284534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting.
    Montecalvo MA; Jarvis WR; Uman J; Shay DK; Petrullo C; Horowitz HW; Wormser GP
    Infect Control Hosp Epidemiol; 2001 Jul; 22(7):437-42. PubMed ID: 11583213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and control of vancomycin-resistant enterococci in a regional neonatal intensive care unit.
    Malik RK; Montecalvo MA; Reale MR; Li K; Maw M; Munoz JL; Gedris C; van Horn K; Carnevale KA; Levi MH; Dweck HS
    Pediatr Infect Dis J; 1999 Apr; 18(4):352-6. PubMed ID: 10223689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing therapy for vancomycin-resistant enterococci (VRE).
    Linden PK
    Semin Respir Crit Care Med; 2007 Dec; 28(6):632-45. PubMed ID: 18095227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic and preventative options for the management of vancomycin-resistant enterococcal infections.
    Kauffman CA
    J Antimicrob Chemother; 2003 Jun; 51 Suppl 3():iii23-30. PubMed ID: 12801939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention and control of the spread of vancomycin-resistant enterococci: results of a workshop held by the German Society for Hygiene and Microbiology].
    Vonberg RP; Chaberny IF; Kola A; Mattner F; Borgmann S; Dettenkofer M; Jonas D; Fahr AM; Klare I; Werner G; Weist K; Wendt C; Gastmeier P;
    Anaesthesist; 2007 Feb; 56(2):151-7. PubMed ID: 17171367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into the epidemiology and control of infection with vancomycin-resistant enterococci.
    Hayden MK
    Clin Infect Dis; 2000 Oct; 31(4):1058-65. PubMed ID: 11049790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin-resistant enterococci.
    Rubinstein E; Keynan Y
    Crit Care Clin; 2013 Oct; 29(4):841-52. PubMed ID: 24094380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of vancomycin-resistant enterococci in the neonatal intensive care unit.
    Singh N; Léger MM; Campbell J; Short B; Campos JM
    Infect Control Hosp Epidemiol; 2005 Jul; 26(7):646-9. PubMed ID: 16092746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for vancomycin-resistant enterococci infection and mortality in colonized patients on intensive care unit admission.
    Kim YJ; Kim SI; Kim YR; Lee JY; Park YJ; Kang MW
    Am J Infect Control; 2012 Dec; 40(10):1018-9. PubMed ID: 22483236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and control of vancomycin-resistant enterococci in an adult and children's hospital.
    Tucci V; Haran MA; Isenberg HD
    Am J Infect Control; 1997 Oct; 25(5):371-6. PubMed ID: 9343618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vancomycin-resistant enterococci (VRE). Recent results and trends in development of antibiotic resistance].
    Klare I; Witte W; Wendt C; Werner G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 Nov; 55(11-12):1387-400. PubMed ID: 23114437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.